, Nov. 30, 2012 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of synthetic biologics and innovative medicines for serious infections and diseases, announced today that
, CEO, will present at the Fifth Annual LD MICRO Conference on
Thursday, December 6, 2012
9:00 a.m. (PT)
. The conference will be held
December 5-6, 2012
at the Luxe Sunset Bel Air Hotel in
Los Angeles, California
. Synthetic Biologics' management will be available during the conference for one-on-one meetings. Please contact LD MICRO to schedule a meeting.
A live webcast of Synthetic Biologics' presentation can be accessed by logging onto the internet at
. After the presentation, a replay will be archived and accessible for 30 days at the same website.
bout Synthetic Biologics, Inc.
Synthetic Biologics is a biotechnology company focused on the development of product candidates for serious infections and diseases. Synthetic Biologics is developing a biologic for the prevention of
infection, and a series of monoclonal antibodies (mAbs) for the treatment of serious infectious diseases, including
. The Company is also developing a synthetic DNA-based therapy for the treatment of pulmonary arterial hypertension (PAH). In addition, the Company is developing a drug candidate for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS, and designing a clinical development pathway for the treatment of amyotrophic lateral sclerosis (ALS). For more information, please visit Synthetic Biologics' website at
SOURCE Synthetic Biologics, Inc.